Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 69683 [2013-27713]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 224 / Wednesday, November 20, 2013 / Notices
Secretary, HHS, on the development of
guidelines under Executive Order
13179; b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Discussed: The agenda
for the conference call includes:
Subcommittee and Work Group
Updates; SEC Petition Evaluations
Update for the January 2013 Advisory
Board Meeting; Plans for the January
2013 Advisory Board Meeting; and
Advisory Board Correspondence.
The agenda is subject to change as
priorities dictate.
Contact Person For More Information:
Theodore M. Katz, M.P.A., Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road NE., Mailstop: E–20,
Atlanta, GA 30333, Telephone (513)
533–6800, Toll Free 1–800–CDC–INFO,
Email ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
tkelley on DSK3SPTVN1PROD with NOTICES
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Jkt 232001
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request; OAA Title
III–E Evaluation
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
16:04 Nov 19, 2013
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Mar<15>2010
Time And Date: 1:00 p.m.–3:00 p.m.,
January 14, 2014 (Closed).
Place: Teleconference
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Effectiveness of Empiric
Antiviral Treatment for Hospitalized
Community Acquired Pneumonia during the
Influenza Season, FOA IP14–001’’.
Contact Person For More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30333,
Telephone: (404) 718–8833.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
Time and Date
8:00 a.m.–5:00 p.m., December 11, 2013.
8:00 a.m.–12:00 p.m., December 12, 2013.
Place: CDC, Global Communications
Center, 1600 Clifton Road NE., Building 19,
Auditorium B3, Atlanta, Georgia 30333.
Status: The meeting is open to the public,
limited only by the space available.
Purpose: The BSC, OID, provides advice
and guidance to the Secretary, Department of
Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of
the National Center for Immunization and
Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases,
and the National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, CDC, in
the following areas: Strategies, goals, and
priorities for programs; research within the
national centers; and overall strategic
direction and focus of OID and the national
centers.
Matters To Be Discussed: The meeting will
include reports from the BSC OID working
groups, brief updates on activities of the
infectious disease national centers; and
focused discussions on 1) the public health
use of molecular-based diagnostics, 2)
school-based efforts to prevent infectious
diseases, and 3) immunization changes at the
state level.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated Federal
Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333,
Telephone: (404) 639–4461.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2013–27717 Filed 11–19–13; 8:45 am]
[FR Doc. 2013–27714 Filed 11–19–13; 8:45 am]
69683
The meeting announced below
concerns Effectiveness of Empiric
Antiviral Treatment for Hospitalized
Community Acquired Pneumonia
during the Influenza Season, Funding
Opportunity Announcement (FOA)
IP14–001, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–27713 Filed 11–19–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
The Administration for
Community Living (ACL) is announcing
an opportunity to comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the information collection requirements
relating to Older Americans Act (OAA)
Title III–E Evaluation.
DATES: Submit written or electronic
comments on the collection of
information by January 21, 2014.
SUMMARY:
E:\FR\FM\20NON1.SGM
20NON1
]]>Agencies
[Federal Register Volume 78, Number 224 (Wednesday, November 20, 2013)]
[Notices]
[Page 69683]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27713]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Effectiveness of Empiric
Antiviral Treatment for Hospitalized Community Acquired Pneumonia
during the Influenza Season, Funding Opportunity Announcement (FOA)
IP14-001, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time And Date: 1:00 p.m.-3:00 p.m., January 14, 2014 (Closed).
Place: Teleconference
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Effectiveness of Empiric Antiviral Treatment for
Hospitalized Community Acquired Pneumonia during the Influenza
Season, FOA IP14-001''.
Contact Person For More Information: Gregory Anderson, M.S.,
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2013-27713 Filed 11-19-13; 8:45 am]
BILLING CODE 4163-18-P
